108552
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
关于格雷夫斯病管理与治疗中患者偏好、期望和价值观的系统综述
Authors Chen Y , Ren Z, Zhou X , Gao P
Received 4 June 2025
Accepted for publication 13 September 2025
Published 19 September 2025 Volume 2025:19 Pages 2949—2957
DOI https://doi.org/10.2147/PPA.S540261
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Johnny Chen
Yingjie Chen,1,* Zonghao Ren,2,* Xiujuan Zhou,3 Peiyang Gao3
1School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, People’s Republic of China; 2Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People’s Republic of China; 3Department of Critical Care Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Peiyang Gao, Department of Critical Care Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People’s Republic of China, Email gaopy930@126.com Xiujuan Zhou, Department of Critical Care Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People’s Republic of China, Email zhouxiujuan@cdutcm.edu.cn
Objective: To systematically synthesize evidence on treatment preferences, values, and expectations among patients with Graves’ disease (GD), in order to understand the disease’s impact on quality of life and inform clinical decision-making..
Methods: PubMed, Embase, Web of Science, and Cochrane Library were searched for articles about GD, patient preferences, and expectations from database inception to December 2024. Studies included in the review must report raw data on patient-reported outcomes, preferences or experiences relating to GD, and must undergo quality assessment according to the Agency for Healthcare Research and Quality (AHRQ).
Results: Twenty-one studies involving patients with GD were included. Although preferences varied, several trends emerged: 1) Most patients reported that GD significantly disrupted their quality of life and social functioning, with 60% experiencing severe discomfort. 2) Antithyroid drugs (ATD) was the most preferred initial treatment (64%), followed by surgery (25%) and radioactive iodine therapy (RAI) (11%), with concerns about radioactivity and surgical complications influencing decisions. 3) Key factors affecting treatment choices included remission rates, recovery time, impact on daily life, and physician recommendations. 4) Graves’ ophthalmopathy (GO) patients faced additional challenges, including social withdrawal and appearance-related distress, with female patients expressing greater concern about disfigurement.
Conclusion: This systematic review indicates that GD, particularly GO, significantly impairs patients’ self-confidence, quality of life, and social functioning. Treatment choices are influenced by expected outcomes, personal circumstances, psychological concerns, and economic factors. ATD remains the preferred first-line treatment, though individual preferences vary significantly, emphasizing the importance of personalized approaches and decision aids.
Keywords: graves disease, patient preferences, shared decision-making, treatment expectations, graves ophthalmopathy, systematic review
1School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, People’s Republic of China; 2Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People’s Republic of China; 3Department of Critical Care Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Peiyang Gao, Department of Critical Care Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People’s Republic of China, Email gaopy930@126.com Xiujuan Zhou, Department of Critical Care Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People’s Republic of China, Email zhouxiujuan@cdutcm.edu.cn
Objective: To systematically synthesize evidence on treatment preferences, values, and expectations among patients with Graves’ disease (GD), in order to understand the disease’s impact on quality of life and inform clinical decision-making..
Methods: PubMed, Embase, Web of Science, and Cochrane Library were searched for articles about GD, patient preferences, and expectations from database inception to December 2024. Studies included in the review must report raw data on patient-reported outcomes, preferences or experiences relating to GD, and must undergo quality assessment according to the Agency for Healthcare Research and Quality (AHRQ).
Results: Twenty-one studies involving patients with GD were included. Although preferences varied, several trends emerged: 1) Most patients reported that GD significantly disrupted their quality of life and social functioning, with 60% experiencing severe discomfort. 2) Antithyroid drugs (ATD) was the most preferred initial treatment (64%), followed by surgery (25%) and radioactive iodine therapy (RAI) (11%), with concerns about radioactivity and surgical complications influencing decisions. 3) Key factors affecting treatment choices included remission rates, recovery time, impact on daily life, and physician recommendations. 4) Graves’ ophthalmopathy (GO) patients faced additional challenges, including social withdrawal and appearance-related distress, with female patients expressing greater concern about disfigurement.
Conclusion: This systematic review indicates that GD, particularly GO, significantly impairs patients’ self-confidence, quality of life, and social functioning. Treatment choices are influenced by expected outcomes, personal circumstances, psychological concerns, and economic factors. ATD remains the preferred first-line treatment, though individual preferences vary significantly, emphasizing the importance of personalized approaches and decision aids.
Keywords: graves disease, patient preferences, shared decision-making, treatment expectations, graves ophthalmopathy, systematic review